Navigation Links
Measurements Poor for Assessing Clinical Trials With Children
Date:4/29/2008

Few studies since 1950 had agreement on standard outcomes, review finds

TUESDAY, April 29 (HealthDay News) -- Few studies consider the appropriate measurements for assessing drug clinical trials that enroll children, say University of Liverpool researchers who reviewed 9,000 pediatric clinical trials conducted since 1950.

They also found that few studies have involved parents, and none have involved children in the process to select which measurements to use in assessing clinical trials.

Before they conduct a clinical trial of a new drug, researchers choose several outcomes -- measurements that provide as much information as possible about the drug's safety, effectiveness and impact on the patients' health and daily life, according to background information in the review.

Children's bodies handle drugs very differently than adults' bodies, and it can't be assumed that drugs that work in adults can simply be used in smaller doses to treat children. Pediatric clinical trials need to be designed with these differences in mind.

Of the 9,000 studies, only 25 met the criteria established by the review and examined the selection of outcomes in clinical research in children. The 25 studies came from 13 groups researching a number of conditions, including asthma, cystic fibrosis and Crohn's disease. However, for many conditions that affect children, there has been no work done into the selection of appropriate outcomes for pediatric clinical trials, the review authors said.

They said reaching agreement on standard outcomes for clinical trials in children is important, because it allows comparison and combination of results from different trials. Standardization also helps avoid selectivity and bias in the conduct of research.

The study was published this week in the journal PLoS Medicine.

More information

The U.S. Food and Drug Administration has more about children and clinical trials.



-- Robert Preidt



SOURCE: Public Library of Science, news release, April 28, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Brain measurements could lead to better devices to move injured or artificial limbs
2. Companies Utilize Variety of Metrics for Quality Measurements
3. MedPAC Again Fails to Evaluate Overall Economic Conditions in Assessing SNF Funding Requirements
4. Extremely low dose CT coronary angiography shows promise in assessing cardiac function
5. Radiologists encouraged to look beyond cancer for clinically unseen diseases
6. Clinical depression linked to abnormal emotional brain circuits
7. Preclinical study suggests organ-transplant drug may aid in lupus fight
8. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
9. Good Clinical Practice Journal Awards: Winners Announced
10. Microsoft Helps Developers of Clinical User Interfaces Improve Efficiency, Patient Safety With Free Toolkit
11. Study Questions Dead-End Cancer Clinical Trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... ... in the greater Dallas, Miami, and Raleigh regions, is organizing an extended charity ... a rare and deadly chromosome abnormality. , After struggling since birth with several ...
(Date:10/13/2017)... ... October 13, 2017 , ... The International Association ... standards of excellence for the field of eating disorders, announces the opening of ... 2018 in Orlando, Florida at the Omni Resort at ChampionsGate. , ...
(Date:10/13/2017)... Calif. (PRWEB) , ... October 13, 2017 , ... Many ... dementia. However, many long-term care insurance companies have a waiver for care if the ... 90-day elimination period, when the family pays for care, is often waived, so the ...
(Date:10/13/2017)... ... October 13, 2017 , ... Talented ... the lowdown on sciatica in a new episode of "Success Files," which is ... events and innovation and investigates each subject in-depth with passion and integrity. , ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... now treating sleep apnea using cutting-edge Oventus O2Vent technology. As many ... sleep disorder characterized by frequent cessation in breathing. Oral appliances can offer significant ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... and NEW YORK , Sept. 27, 2017 ... mobile health and big data solutions, today announced that its MyDario product ... check your local TV listings for when The Dr. Oz Show airs ... The ... this month. ...
(Date:9/23/2017)... Janssen Biotech, Inc. (Janssen) announced today that ... U.S. Food and Drug Administration (FDA) for the Biologics ... treatment of moderately to severely active rheumatoid arthritis (RA). ... needed to further evaluate the safety of sirukumab in ... "We are disappointed ...
(Date:9/19/2017)... 2017 HistoSonics, Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, ... three leadership team developments today:   ... ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has ...
Breaking Medicine Technology: